Results 121 to 130 of about 18,985 (204)

Zoledronic Acid Inhibits the Growth of ER-Positive Breast Cancer Cells by Inducing Ferroptosis. [PDF]

Biomol Ther (Seoul)
Yuan S, Shi D, Xu Y, Wu T, Liang S, Chen D, Wang J, Wu G, Cao J.   +8 more
europepmc   +1 more source

Case Report: Zoledronic acid-induced hyperprogression in oncology: a case study of RET-driven neuroendocrine carcinoma treated with Selpercatinib. [PDF]

Front Oncol
Liu J, He F.
europepmc   +1 more source

Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis

, 2016
Zoledronic acid is widely used for the treatment of various skeletal disorders. While acute phase reactions are commonly seen, hypocalcaemia, femoral shaft fractures, osteonecrosis of the jaw and renal failure are rare.
Donthireddy, Vijayalakshmi, Rao, Sudhaker D, Kulkarni, Pooja, Cushman, Terra   +3 more
core  

Dose-, duration- and age-dependent effects of zoledronic acid on bone structure and mechanical properties in growing rice rats. [PDF]

Front Endocrinol (Lausanne)
Aguirre JI, Messer JG, Castillo EJ, da Silva Frota Gomes TL, Urrego CA, Kohn DH, Kimmel DB.   +6 more
europepmc   +1 more source

Efficacy and safety of denosumab, zoledronic acid and alendronate on bone mineral density and trabecular bone score in men with osteoporosis. [PDF]

Age Ageing
Zhou B, Zhang Y, Yu W, Sun L, Wang Y, Jiang Y, Wang O, Xing X, Xia W, Zhang J, Yan W, Li M.   +11 more
europepmc   +1 more source

An Unknown Side Effect of Zoledronic Acid: Acute Pancreatitis

Endocrinology Research and Practice
Bisphosphonates are widely used to treat several clinical conditions. Zoledronic acid is one of these classes, commonly used for the treatment and prevention of osteoporosis, hypercalcemia of malignancy, Paget’s disease, and multiple myeloma.
Ayça Demirel, Mustafa Şentürk, Özlem İyidir Turhan, Neslihan Başçıl Tütüncü   +3 more
doaj  

Hesperetin modulates osteoprogenitor cells and macrophages under zoledronic acid and inflammatory stress. [PDF]

Arch Oral Biol
Mendes Soares IP, Liepman O, Anselmi C, Chang S, Hebling J, Dal-Fabbro R, Bottino MC.   +6 more
europepmc   +1 more source

Case report of severe hypocalcemia with atypical symptoms after zoledronic acid in palliative care: a deprescribing pitfall. [PDF]

BMC Palliat Care
Arnold T, Berner-Sharma J, Rudolph D, Bausewein C, Rémi C.   +4 more
europepmc   +1 more source

The Complex of Copper (II) and Zoledronic Acid: Relevance to Oxidative Death of Leukemia Cells in the Bone Marrow. [PDF]

Int J Mol Sci
Barskaya ES, Savin AM, Chernov KV, Petrova AS, Abramovich MS, Maksimova YA, Dubenskiy AS, Tsymbal SA, Lantsova AV, Moiseeva AA, Beloglazkina MA, Borisov RS, Beloglazkina EK, Shtil AA.   +13 more
europepmc   +1 more source

Breast-cancer Adjuvant Therapy With Zoledronic Acid

BACKGROUND: Data suggest that the adjuvant use of bisphosphonates reduces rates of recurrence and death in patients with early-stage breast cancer. We conducted a study to determine whether treatment with zoledronic acid, in addition to standard adjuvant
Peterson, Jennifer, Coleman, Robert E., Dodwell, David, Burkinshaw, Roger, Gregory, Walter, Gil Gil, Miguel, Marshall, Helen, Bell, Richard, Ritchie, Diana, Cameron, David, Keane, Maccon, Rea, Una, Davies, Claire, Houston, Stephen J., Gaunt, Claire, Grieve, Robert J., Hiley, Victoria, Barrett-Lee, Peter J., Pugh, Julia   +18 more
core